Status:
RECRUITING
Psychotherapy Intervention for Latinos With Advanced Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
Lincoln Medical and Mental Health Center
Conditions:
Solid Tumor
Solid Tumor, Adult
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to adapt a counseling intervention called Meaning Centered Psychotherapy to make it culturally relevant for Latinos. Cancer affects patients and their loved ones. Latinos ...
Detailed Description
Overview of the Study. This project has four phases. In the first two phases the study team will work to gain an understanding of the sources of meaning, hope, legacy and identity in Latino patients w...
Eligibility Criteria
Inclusion
- Phase I: Quantitative
- Diagnosed with stages III or IV solid tumor cancer \*(as per self report for ICCAN patients)
- Age 18 or older
- As per self report, Latino/a or Hispanic ethnicity
- As per self report, fluent in oral Spanish (monolingual) or fluent in oral Spanish and English (bilingual)
- Phase 2: Qualitative
- Enrolled in the quantitative phase of study (as seen above)
- Completes the quantitative phase questionnaire package
- Scores above or below the threshold for the Distress Thermometer (DT≥4 or ≤3)
- In the judgment of the investigator, willing and able to be interviewed in Spanish only
- Agrees to be audio- recorded
- Phase 3: Provider Feedback
- Professionals working in the mental health field;
- Have a caseload of five or more Latino cancer patients per month
- Able to communicate and read in Spanish
- Agrees to be audio or video-recorded
- Phase 4: Patient Feedback
- Diagnosed with stages III or IV solid tumor cancer \*(as per self report for ICCAN patients)
- Age 18 or older
- As per self report, Latino/a or Hispanic ethnicity
- In the judgment of the investigator, willing and able to be interviewed in Spanish only
- Agrees to be audio-recorded
Exclusion
- Phase 1: Quantitative
- In the judgment of the treating physician and/or the consenting professional, presence of significant cognitive impairment (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection
- In the judgment of the consenting professional, significant or major disabling medical or psychiatric condition sufficient to preclude meaningful informed consent, interview, or completion of assessment measures (patients whose psychiatric disorder is well controlled by treatment will be eligible)
- Phase 2: Qualitative
- In the judgment of the treating physician and/or the consenting professional, presence of significant cognitive impairment (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection
- In the judgment of the consenting professional, significant or major disabling medical or psychiatric condition sufficient to preclude meaningful informed consent, interview, or completion of assessment measures (patients whose psychiatric disorder is well controlled by treatment will be eligible)
- Phase 4: Patient Feedback
- Diagnosed with a major disabling medical or psychiatric condition
- Unable to understand the consent procedure
- Too ill to participate, all as reported by the patient and/or determined by the investigator's judgment.
Key Trial Info
Start Date :
April 20 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT04015609
Start Date
April 20 2015
End Date
August 31 2026
Last Update
October 2 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
2
Ralph Lauren Center for Cancer Care and Prevention
New York, New York, United States
3
Lincoln Medical and Mental Health Center
The Bronx, New York, United States
4
Ponce Health Sciences University
Ponce, Puerto Rico, 00732